A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

New options for testing and treating some of the most common sexually transmitted diseases are becoming available ...

Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.

The UK National Screening Committee’s recent recommendation to introduce prostate cancer screening for men with faulty BRCA ...

Pearson is preparing to introduce palm‑print biometrics across its global testing network through a new partnership with ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

Menopause and prostate problems will be among the priorities for the NHS’s revolutionary new online hospital when it launches next year. The NHS has selected nine common conditions which will be the ...

MENOPAUSE and prostate patients will be some of the first to use the new NHS “online hospital” next year. The completely ...

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

While a PSA of 12.9 ng/ml does raise concern, it does not automatically mean cancer, noted Dr Saraf. “The risk depends on age ...